Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Extends reach of the drug

- PMLiVE

Regeneron scores positive data in phase 3 cholesterol trial

Targets severe inherited disorder

Roche Basel Switzerland

Roche undercuts price of Bayer cancer drug after winning FDA approval

Both drugs highly effective in small subset of patients

- PMLiVE

Putting our core values into practice at the Porterhouse summer social

As a reward for all our hard work and in keeping with our core values, which include ‘family’ and ‘humour and happiness’, the teams at Porterhouse enjoy regular socials.For our...

Porterhouse Medical Group

- PMLiVE

Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit

Additional preparation to ensure continuity of supplies

- PMLiVE

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices

- PMLiVE

Potential cure for Ebola following trial success

Two treatments increased rates of survival

- PMLiVE

AZ, Merck’s Lynparza scores market-expanding clinical success

Positive phase 3 findings in ovarian cancer

Spotlight interview: 15 minutes on patient engagement in pharma

Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma

OPEN Health

- PMLiVE

Health Unlimited supports ‘Serviceplan Health’ network launch

Expands reach into Europe

- PMLiVE

A new leadership appointment at Porterhouse Medical

Porterhouse Medical Group is thrilled to announce the promotion of Jamie Harrison to Scientific Team Lead.Jamie is a key member of the Scientific Services team and has been central to...

Porterhouse Medical Group

- PMLiVE

Novartis chooses internal replacement for US pharma president role

Victor Bulto to lead US pharma business

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links